Health
Gilead widens battle against alleged counterfeit HIV drug ri
September 28, 2022
Our Latest News In:
health
health
Health
Biogen, Eisai stocks soar on Alzheimer's success, lifting ri
September 28, 2022
Health
GM delays return-to-work plans to 2023
September 27, 2022
Health
Europe's generic drugmakers may cut output due to surging en
September 27, 2022
Health
Pfizer CEO tests positive for COVID
September 24, 2022
Health
Cathay Pacific to increase flight frequencies after Hong Kon
September 23, 2022
Health
Juul sues FDA for documents said to justify e-cigarette ban
September 20, 2022
Health
Haleon rejects Zantac indemnification requests from GSK, Pfi
September 20, 2022
Health
Marriott coaxing workers back to office with $600 million bu
September 19, 2022
Health
Consumer group says drugmakers abuse U.S. patent system to k
September 15, 2022
Health
Swiss competition watchdog probes Novartis over patent use
September 15, 2022
Health
Philip Morris appoints two former U.S. FDA officials to key
September 14, 2022
Health
AstraZeneca beats US shareholder lawsuit over COVID-19 vacci
September 12, 2022
Health
Amgen says Lumakras cuts risk of lung cancer progression by
September 11, 2022
Health
CATL's battery unit operates in compliance with COVID curbs
September 09, 2022
Health
Volvo Cars resumes limited production at one China plant
September 09, 2022
DJIA SNAPSHOT
* Market data is delayed
MARKET INFORMATION
| LAST | CHG | %CHG | |
| DJIA | 29,676.00 | +0 | 0 %  |
| NASDAQ | 262.00 | +0 | 0 % |
| S&P 500 | 0.00 | +0 | 0 % |
| OIL | 2,905.00 | +0 | 0 % |
|
WE PROFILE LOTS OF AMAZING STOCKS
Our job and our
passion is sharing awesome companies that can be overlooked by wallstreet. We love
finding the diamonds in the rough that could turn into the next big mover in the
markets and we enjoy sharing ideas in our Investor Alley with picks like these:
|
The content on this site is not a solicitation to buy or sell securities and should be regarded as "entertainment use only". Each content provider featured on DearWallstreet.com has their own opinion and bias and may not share similar views as DearWallstreet.com. DearWallstreet.com is not a registered financial advisor, or registered financial advisory firm. Any statement or opinion presented on DearWallstreet.com should be considered "as is" without warranties of any kind either expressed or implied, and should NOT be considered investment advice. By using this site, you agree to the terms presented in our Full Disclosure & Disclaimer Page.
© 2022 Dear Wallstreet.com | 11138 Del Amo Blvd. #359 Lakewood, CA 90715
